Assessment of Dietary Protein Needs of Older Women

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Wayne Campbell, Purdue University
ClinicalTrials.gov Identifier:
NCT01193946
First received: July 27, 2010
Last updated: January 16, 2013
Last verified: January 2013

July 27, 2010
January 16, 2013
May 2010
November 2011   (final data collection date for primary outcome measure)
dietary protein requirement in older women [ Time Frame: 3 month ] [ Designated as safety issue: No ]
Dietary protein requirement is assessed by the subjects' differential response to different dietary protein intake
Same as current
Complete list of historical versions of study NCT01193946 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Assessment of Dietary Protein Needs of Older Women
Assessment of Dietary Protein Needs of Older Women

The purpose of this study is to evaluate dietary protein requirements in elderly women aged 80 years and older using the indicator amino acid oxidation technique.

Hypothesis to be tested: Protein requirement for elderly women is higher than the estimated average requirement of 0.66 g∙kg-1∙d-1 protein. The recommended protein intake for elderly women is higher than the recommended dietary allowance of 0.80 g∙kg-1∙d-1 protein.

There is currently considerable debate regarding the accuracy of the estimated average requirement (EAR) and the recommended dietary allowance (RDA) for older people. Very limited data obtained from older individuals are available to support the assumption that age does not affect protein requirement. Existing method like nitrogen balance has inherent limitations that diminish it from being considered a reference method. Indicator amino acid oxidation technique is emerging as an alternative method to measure dietary protein requirement. It is more accurate and less demanding. The current study will be the first time this technique is used with elderly adults and will provide an important foundation for geriatric nutrition research.

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:

plasma samples

Probability Sample

Female Age range: 80 yrs and older Body mass index between 22-30 Weight stable 4.5 kg weight gain or loss within the last 6 month Non-smoking within the last 6 month Ambulatory Clinically normal blood profiles within 10% of clinical normalcy. No diseases or not taking medications known to influence protein or energy metabolism, Willingness and ability to consume food provided and not allergic to phenylalanine

Protein-energy; Imbalance
Dietary Supplement: dietary control
Seven dietary protein levels will be tested randomly on the 7 testing days: 0.10, 0.30, 0.60, 0.90, 1.2, 1.5, and 1.8 g∙kg-1∙d-1.
Single-arm design
There is currently considerable debate regarding the accuracy of the estimated average requirement (EAR) and the recommended dietary allowance (RDA) for older people. Very limited data obtained from older individuals are available to support the assumption that age does not affect protein requirement. Existing method like nitrogen balance has inherent limitations that diminish it from being considered a reference method. Indicator amino acid oxidation technique is emerging as an alternative method to measure dietary protein requirement. It is more accurate and less demanding. The current study will be the first time this technique is used with elderly adults and will provide an important foundation for geriatric nutrition research
Intervention: Dietary Supplement: dietary control
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
8
December 2011
November 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Female
  • Age range: 80 yrs and older
  • Body mass index between 22-30
  • Weight stable 4.5 kg weight gain or loss within the last 6 month
  • Non-smoking within the last 6 month
  • Ambulatory
  • Clinically normal blood profiles within 10% of clinical normalc.
  • No diseases or not taking medications known to influence protein or energy metabolism,
  • Willingness and ability to consume food provided and not allergic to phenylalanine
  • Continent, strong bladder control

Exclusion Criteria:

  • Male,
  • Gained or lost more than 4.5 kg of body weight within the last 6 months,
  • Non-ambulatory (i.e. bedridden, wheel-chair bound),
  • Clinically abnormal blood profiles as identified by our study physician, Arthur Rosen, MD
Female
80 Years and older
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01193946
1001008857, UL1RR025761
No
Wayne Campbell, Purdue University
Purdue University
National Center for Research Resources (NCRR)
Principal Investigator: Wayne W Campbell, Ph.D. Purdue University
Purdue University
January 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP